Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
- Butterfield D. A., Oeswein J. Q., Markesbery W. R. Electron spin resonance study of membrane protein alterations in erythrocytes in Huntington's disease. Nature. 1977 Jun 2;267(5610):453–455. doi: 10.1038/267453a0. [DOI] [PubMed] [Google Scholar]
- Gale J. S., Bird E. D., Spoke E. G., Ivejsen L. L., Jessel T. Human brain substance P: distribution in controls and Huntington's chorea. J Neurochem. 1978 Mar;30(3):633–634. doi: 10.1111/j.1471-4159.1978.tb07818.x. [DOI] [PubMed] [Google Scholar]
- Goetz I., Roberts E., Comings D. E. Fibroblasts in Huntington's disease. N Engl J Med. 1975 Dec 11;293(24):1225–1227. doi: 10.1056/NEJM197512112932403. [DOI] [PubMed] [Google Scholar]
- Gray P. N., May P. C., Mundy L., Elkins J. L-Glutamate toxicity in Huntington's disease fibroblasts. Biochem Biophys Res Commun. 1980 Jul 31;95(2):707–714. doi: 10.1016/0006-291x(80)90843-8. [DOI] [PubMed] [Google Scholar]
- Harper P. S., Walker D. A., Tyler A., Newcombe R. G., Davies K. Huntington's chorea. The basis for long-term prevention. Lancet. 1979 Aug 18;2(8138):346–349. doi: 10.1016/s0140-6736(79)90356-8. [DOI] [PubMed] [Google Scholar]
- Ingelfinger F. J. Arrogance. N Engl J Med. 1980 Dec 25;303(26):1507–1511. doi: 10.1056/NEJM198012253032604. [DOI] [PubMed] [Google Scholar]
- Klawans H. L., Goetz C. G., Paulson G. W., Barbeau A. Levodopa and presymptomatic detection of Huntington's disease--eight-year follow-up. N Engl J Med. 1980 May 8;302(19):1090–1090. doi: 10.1056/NEJM198005083021916. [DOI] [PubMed] [Google Scholar]
- Manyam N. V., Katz L., Hare T. A., Gerber J. C., 3rd, Grossman M. H. Levels of gamma-aminobutyric acid in cerebrospinal fluid in various neurologic disorders. Arch Neurol. 1980 Jun;37(6):352–355. doi: 10.1001/archneur.1980.00500550054006. [DOI] [PubMed] [Google Scholar]
- Moshell A. N., Tarone R. E., Barrett S. F., Robbins J. H. Radiosensitivity in Huntington's disease: implications for pathogenesis and presymptomatic diagnosis. Lancet. 1980 Jan 5;1(8158):9–11. doi: 10.1016/s0140-6736(80)90550-4. [DOI] [PubMed] [Google Scholar]
- Noronha A. B., Roos R. P., Antel J. P., Arnason B. G. Huntington's disease: abnormality of lymphocyte capping. Ann Neurol. 1979 Nov;6(5):447–450. doi: 10.1002/ana.410060512. [DOI] [PubMed] [Google Scholar]
- Perry T. L., Hansen S., Kloster M. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain. N Engl J Med. 1973 Feb 15;288(7):337–342. doi: 10.1056/NEJM197302152880703. [DOI] [PubMed] [Google Scholar]
- Perry T. L., Wright J. M., Hansen S., Allan B. M., Baird P. A., MacLeod P. M. Failure of aminooxyacetic acid therapy in Huntington disease. Neurology. 1980 Jul;30(7 Pt 1):772–775. doi: 10.1212/wnl.30.7.772. [DOI] [PubMed] [Google Scholar]
- Perry T. L., Wright J. M., Hansen S., MacLeod P. M. Isoniazid therapy of Huntington disease. Neurology. 1979 Mar;29(3):370–375. doi: 10.1212/wnl.29.3.370. [DOI] [PubMed] [Google Scholar]
- Pettegrew J. W., Nichols J. S., Stewart R. M. Fluorescence spectroscopy on Huntington's fibroblasts. J Neurochem. 1979 Oct;33(4):905–911. doi: 10.1111/j.1471-4159.1979.tb09920.x. [DOI] [PubMed] [Google Scholar]